LIXT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
LIXT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.
Lixte Biotechnology Holdings's change in deferred tax for the three months ended in Jun. 2024 was $0.00 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Jun. 2024 was $0.00 Mil.The historical data trend for Lixte Biotechnology Holdings's Deferred Tax can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lixte Biotechnology Holdings Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Deferred Tax | Get a 7-Day Free Trial | - | - | - | - | - |
Lixte Biotechnology Holdings Quarterly Data | ||||||||||||||||||||
Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | |
Deferred Tax | Get a 7-Day Free Trial | - | - | - | - | - |
Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.
Deferred Tax for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Lixte Biotechnology Holdings's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.
Rene Bernards | director | KONINGSVAREN 37, ABCOUDE P7 1391AD |
Van Der Baan Bastiaan Jeroen | director | HOGEWEG 4-H, AMSTERDAM P7 1098CB |
Eric Forman | 10 percent owner | 117 E. 29TH ST., APT. 5A, NEW YORK NY 10016 |
Regina Brown | director | 248 ROUTE 25A, NO. 2, EAST SETAUKET NY 11733 |
Glenn Krinsky | 10 percent owner | C/O SRKP 1, INC., 1900 AVENUE OF THE STARS, SUITE 310, LOS ANGELES CA 90067 |
Yun Yen | director | 1301 OAKLAWN ROAD, ARCADIA CA 91006 |
Robert Greenberg | 10 percent owner | SKECHERS USA INC, 228 MANHATTAN BEACH BLVD, MANHATTAN BEACH CA 90266 |
Gil Schwartzberg | 10 percent owner | 269 S. BEVERLY DR., #1315, BEVERLY HILLS CA 90212 |
Philip F Palmedo | director | 1801 CENTURY PARK EAST #1600, LOS ANGELES CA 90067 |
John S Kovach | director, 10 percent owner, officer: Pres., CFO & Secty | 1801 CENTURY PARK EAST #1600, LOS ANGELES CA 90067 |
Stephen J. Forman | director | 248 ROUTE 25A, NO. 2, EAST SETAUKET NY 11733 |
Hung Tak Ho | 10 percent owner | MAYFAIR BY THE SEA II, TOWER T8, 1/F, UNIT A, 21 FO CHUN ROAD, PAK SHEK KOK, TAIPO K3 00000 |
Robert N Weingarten | officer: Vice President and CFO | 5439 LOCKHURST DRIVE, WOODLAND HILLS CA 91367 |
James Miser | officer: Chief Medical Officer | 680 E COLORADO BLVD., SUITE 180, PASADENA CA 91101 |
Jane Merrill Riggs | 10 percent owner | 4852 SAINT ANDRES AVENUE, LA VERNE CA 91750 |
From GuruFocus
By Marketwired • 08-15-2024
By Marketwired • 05-20-2024
By Marketwired • 06-14-2024
By Marketwired • 08-26-2024
By GuruFocus Research • 02-07-2024
By Marketwired • 06-14-2024
By GuruFocusNews GuruFocusNews • 07-05-2022
By Value_Insider Value_Insider • 10-13-2022
By Marketwired • 09-04-2024
By ACCESSWIRE • 08-15-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.